Product information

Atrovent HFA 20 µg/dose
200 doses
ipratropium
2084556
7.27 / 10
Locked

Product properties

22254-24-6
R03BB01
Boehringer Ingelheim
Pressurised inhalation, solution
€4.10
BE240335
04048846015839
M1
Public
240335-01

Pharmacist Assessment

Normally available

This product has good current availability (score 7.27/10) and is historically stable (score 🔒/10). No action required.

Note: commercialization of this product will be stopped on 01/12/2026.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 14 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Planned
From 01/12/2026

Other reason

Under evaluation
Available Active
Until 30/11/2026

Composition

2 ingredients

Substance Type Strength CAS
Active ingredient
21 ug/{dose}
66985-17-9
Excipient
2190 mg

Additional information

Availability statistics

Available
0 days
3
0